Pinto Marin, Alvaro alvaro.pinto@uam.es
Publications
- Articles 47
- Books 0
- Book chapters 2
- Conferences 0
- Working papers 1
- Technical reports 0
- Research projects 0
- Supervised theses 0
- Patent or software license 0
Adjuvant immunotherapy in muscle-invasive bladder cancer: Closer than it seems?
- Pinto
- Álvarez-Maestro M
Actas Urologicas Espanolas (p. 567-568) - 1/11/2021
10.1016/j.acuro.2021.05.003 View at source
- ISSN 02104806
Avanzando en el tratamiento del paciente con carcinoma urotelial localmente avanzado
- Alvaro Pinto Marín
Revisiones En Cancer - 1/1/2024
- ISSN 02138573
- iMarina
Biological molecular layer classification of muscle-invasive bladder cancer opens new treatment opportunities
- Trilla-Fuertes, L
- Gámez-Pozo, A
- Prado-Vázquez, G
- Zapater-Moros, A
- Díaz-Almirón, M
- Arevalillo, JM
- Ferrer-Gómez, M
- Navarro, H
- Maín, P
- Espinosa, E
- Pinto, A
- Vara, JAF
BMC Cancer - 28/6/2019
Editor: BioMed Central Ltd.
10.1186/s12885-019-5858-z View at source
- ISSN 14712407
- ISSN/ISBN 1471-2407
Case–control study assessing the impact of COVID19 in advanced kidney cancer patients treated with antiangiogenics or immunotherapy: the COVID-REN study
- García-Donas J
- de Velasco G
- Madurga R
- Chamorro J
- Rosero D
- Etxaniz O
- Pérez-Gracia JL
- Pinto Á
- Cacho D
- Barba M
- Borrega P
- Lázaro M
- Rodriguez L
- Villalobos L
- García L
- Cuellar A
- Solís-Hernández MP
- González A
- Pernaut C
- Rodríguez-Moreno JF
Clinical & Translational Oncology - 1/3/2024
10.1007/s12094-023-03295-2 View at source
- ISSN 1699048X
Circulating levels of the interferon-γ-regulated chemokines cxcl10/cxcl11, il-6 and hgf predict outcome in metastatic renal cell carcinoma patients treated with antiangiogenic therapy
- Esteban E
- Exposito F
- Crespo G
- Lambea J
- Pinto A
- Puente J
- Arranz JA
- Redrado M
- Rodriguez-Antona C
- de Andrea C
- Lopez-Brea M
- Redin E
- Rodriguez A
- Serrano D
- Garcia J
- Grande E
- Castellano D
- Calvo A
Cancers - 1/6/2021
10.3390/cancers13112849 View at source
- ISSN 20726694
Clinical Factors Associated With Long-Term Benefit in Patients With Metastatic Renal Cell Carcinoma Treated With Axitinib: Real-World AXILONG Study
- Pinto, A
- Reig, O
- Iglesias, C
- Gallardo, E
- García-del Muro, X
- Alonso, T
- Anguera, G
- Suárez, C
- Muñoz-Langa, J
- Villalobos-León, L
- Rodríguez-Sánchez, A
- Lainez, N
- Martínez-Ortega, E
- Campayo, M
- Velastegui, A
- Rodriguez-Vida, A
- Villa-Guzmán, JC
- Méndez-Vidal, MJ
- Rubio, G
- García, I
- Capdevila, L
- Lambea, J
- Vázquez, S
- Fernández, O
- Hernando-Polo, S
- Cerezo, S
- Santander, C
- García-Marrero, R
- Zambrana, F
- González-del Alba, A
- Lazaro-Quintela, M
- Castellano, D
- Chirivella, I
- Anido, U
- Viana, A
- García, A
- Sotelo, M
- Arévalo, MG
- García-Donas, J
- Hernández, C
- Bolós, MV
- Llinares, J
- Climent, MA
Clinical Genitourinary Cancer (p. 25-34) - 1/2/2022
10.1016/j.clgc.2021.09.006 View at source
- ISSN 15587673
Colony-stimulating factors: clinical evidence for treatment and prophylaxis pf chemotherapy-induced febrile neutropenia
- Alvaro Pinto Marín
- César Gómez Raposo
Clinical & Translational Oncology (p. 729-734) - 1/1/2006
- ISSN 1699048X
- iMarina
Consensus Recommendations from the Spanish Germ Cell Cancer Group on the Use of High-dose Chemotherapy in Germ Cell Cancer
- González-Billalabeitia, E
- Sepúlveda, JM
- Maroto, P
- Aparicio, J
- Arranz, JA
- Esteban, E
- Gironés, R
- López-Brea, M
- Mendez-Vidal, MJ
- Pinto, A
- Sastre, J
- de Prado, DS
- Terrasa, J
- Vazquez, S
- Powles, T
- Beyer, J
- Castellano, D
- del Muro, XG
European Urology Focus (p. 280-286) - 1/4/2017
10.1016/j.euf.2016.07.002 View at source
- ISSN 24054569
Cómo está cambiando enfortumab vedotina la vida de los pacientes
- Alvaro Pinto Marín
Revisiones En Cancer (p. 4-5) - 1/1/2023
- ISSN 02138573
- iMarina
This researcher has no books.
Enfermedad tromboembólica
- Ana Sundlov
- Alvaro Pinto Marín
Tratado De Medicina Paliativa Y Tratamiento De Soporte Del Paciente Con Cáncer (p. 567-573) - 1/1/2007
- iMarina
This researcher has no conferences.
This researcher has no technical reports.
This researcher has no research projects.
This researcher has no supervised thesis.
This researcher has no patents or software licenses.
Researcher profiles
-
ORCID
-
Scopus Author ID
-
Dialnet id